Independence gains value: Recent radiopharma transactions highlight the strategic value of EUZ's independent ...

Recent radiopharma acquisitions underline the value of EUZ's core capabilities: independent isotope supply and specialist manufacturing. Strategic and financial investors are acquiring comparable i...